US infectious diseases expert, Professor Daniel Hoft, joins Scientific Advisory Board 25 November 2021- Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical-stage infectious disease pharmaceutical company with a